It’s one thing to keep up with this as an individual organization. It becomes an even bigger game when partnerships begin to form, collaborations occur, and technologies connect. Companies are forming alliances to uncover new ways to diagnose complex health issues, conduct new drug studies, and provide personalized treatments. Several of these partnerships have already been announced, and we can certainly see many more to come. (1)

Don’t forget the people

These trends point to another reality that is often overlooked when we talk about digital transformation; it’s not just about the technology; it’s also about the people and their drive to innovate. “The future of life science R&D is dependent upon having a creative and engaged community of innovators, from a pipeline of new talent to activating creatives from other disciplines.” (2)

These innovators aren’t just in product development and engineering, many innovations – and their digital innovators – can also be found in production and logistics, as two common examples. This trend drives the need for upskilled workers covering many facets of the life sciences business. (3)

It’s not a cliché; life sciences organizations are realizing that the key to competitive differentiation is their people. (4)

It’s up to each organization to align their technology, processes, and talent with their business operations to ensure we keep in sight what matters most: patient safety.

Citations:

1 – “Life Sciences Companies Leverage New Partnerships Against Severe Diseases,” Biospace, February 2022

2 – “Life Sciences SUPerMInD,” MilliporeSigma/MIT, December 2021

3 – “U.S. Life Sciences Industry Digitizing to Meet Pandemic-Related Demands,” Information Services Group, February 2022

4 – “The Key To Competitive Differentiation In Life Sciences Is People,” Life Science Leader, February 2022